Re: [Geuvadis_rnaseq] reminder Geuvadis TC tomorrow 11am

Sorry, I am on my way to Chicago and will not be able to attend. Philip the same. Kind regards Stefan From: geuvadis_rnaseq-bounces(a)lists.crg.es [mailto:geuvadis_rnaseq-bounces@lists.crg.es] On Behalf Of Thomas Giger Sent: Donnerstag, 5. Mai 2011 17:37 To: geuvadis_rnaseq(a)lists.crg.es Subject: [Geuvadis_rnaseq] reminder Geuvadis TC tomorrow 11am Dear All, This message is a reminder for the Geuvadis RNAseq phone conference that will take place tomorrow May 6 from 11am - 12pm CEST. Here again the most important information for this call (the same information as in my mail from April 26): To participate in this call you have to do the following: - if you call in from Switzerland dial: +41 58 262 07 22 - otherwise from other countries please find enclosed the list with the "local access numbers for teleconferences" and dial the number corresponding to your country. Then enter the PIN: 611683 In case you need assistance during the call - dial "OO" (nil nil) to get in touch with an operator. I have written down the following points that should be discussed: 1. As of now we made plans that the different labs analyze samples from one particular population (as listed in the workflow document that I've sent around on April 7). It would be a better experimental design if the samples were randomly distributed among the different labs. Since there is still time to react - do we want to switch the strategy? 2. How long are the library prep / sequencer queue up times in the different labs (once you receive the RNA samples - how long do you think will it take you to analyze them?). If some labs expect to have much larger delays, we could make arrangements that those labs get samples earlier than other labs. This would also mean that we would all use the protocol that is used at the time point when the first lab starts to analyze samples. 3. Which other samples (other than the 500 1KGP European samples) should be analyzed by RNAseq? 4. Specifications for the small RNA protocol. Looking forward to talk to you tomorrow, Thomas ------------------------------------------------------------------------ Thomas Giger, Ph.D. Department of Genetic Medicine and Development University of Geneva Medical School 1 Rue Michel-Servet Geneva 1211 Switzerland